ABEO

ABEONA THERAPEUTICS INC

ABEO·00289Y206·US·Common Stock·Healthcare - Biotechnology-13D/G

ABEO (ABEONA THERAPEUTICS INC) is held by 70 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($14.3M), VANGUARD CAPITAL MANAGEMENT LLC ($9.7M), GEODE CAPITAL MANAGEMENT, LLC ($5.4M). Net institutional sentiment: Mixed.

70
Holders
(7 Elite)
$71.7M
Total Value
56% (64)
Consensus
36 buying - 28 selling
13F: Insider & Congress:
ABEOSmart Money Verdict
View all
Held by 70 funds
7 elite
Who's Trading
InsiderSVSeshadri VishwasSell $473KJul 9, 2026
InsiderVWVazzano Joseph WalterSell $173KJul 9, 2026
InsiderOMO'Malley Brendan M.Sell $84KJul 9, 2026
InsiderVMVasanthavada MadhavSell $88KJul 9, 2026
ActivistNANantahala Capital Management, LLC10.0%May 15, 2026
ActivistNPNANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP5.8%May 15, 2026
InsiderCECrombez EricSell $145KMay 15, 2026
InsiderVMVasanthavada MadhavSell $33KMay 11, 2026
ActivistOHOrin Hirschman5.4%Apr 28, 2026
ActivistFUFunicular Funds, LP5.3%Apr 6, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.2M(+1.1%)$14.3M0.0%+22.56%
28
New
2.2M$9.7M0.0%+41.30%
38
Increased
1.2M(+6.4%)$5.4M0.0%-0.22%
29
Increased
1.1M(+125.1%)$5.1M0.0%+36.93%
43
Increased
957,328(+6.5%)$4.3M0.0%+30.26%
29
Decreased
589,847(-0.3%)$2.6M0.0%+34.75%
0
Increased
522,445(+0.3%)$2.3M0.0%+24.34%
26
New
500,000$2.2M0.0%+41.30%
36
Increased
435,973(+4.0%)$2M0.0%+38.01%
27
Decreased
432,370(-38.4%)$1.9M0.0%+34.75%
0
Increased
425,426(+23.8%)$1.9M0.0%+36.23%
31
Decreased
394,274(-22.3%)$1.8M0.0%+27.79%
0
New
339,515$1.5M0.0%+41.30%
35
Decreased
337,562(-28.7%)$1.5M0.0%+29.32%
0
New
270,976$1.2M0.0%+41.30%
35
Increased
266,497(+1148.4%)$1.1M0.0%+39.96%
41
Increased
233,924(+45.8%)$1M0.0%+33.26%
34
New
216,305$969,0470.0%+41.30%
35
Decreased
209,607(-35.3%)$939,0390.0%+33.34%
0
Increased
199,145(+19.5%)$892,1700.0%+32.65%
29

Showing 1-20 of 72

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used